Company: APXIF
Filing Date: 2025-06-13
Form Type: F-4/A
Source: 0001213900-25-054324
Chunk: 356

Company: APx Acquisition Corp. I
Filing Date: 2025-06-13
Form: F-4/A
Chunk 356
---
 experts, to enhance the scalability and sophistication of our future AI systems. • Making genetic information more accessible and equitable: as sequencing and technology costs decrease over time, we are determined to keep healthcare within reach and committed to making genetic services more accessible and affordable. • Focusing on actionable results: we are dedicated to delivering personalized, clinically actionable insights that empower individuals to make informed health decisions. We aim to proactively address potential or unidentified health issues, providing individuals with the knowledge they need to take control of their health and well -being. • Ensuring privacy, security and reliability: we are committed to ensuring that our users’ genetic, clinical and lifestyle data and information is treated with the highest standards of confidentiality and integrity. To protect sensitive customer data, we employ comprehensive safeguards, including encryption, access controls, data anonymization, and compliance with relevant data protection regulations, prioritizing security and privacy at each stage of AI development. Currently, all AI developments are conducted in -house, ensuring strict oversight. We believe that timely and precise genomic insights play a critical role in revolutionizing individual health management. In today’s landscape, reliable genetic data remains elusive for many, leaving them vulnerable to undetected disease -pronegenetic variants. According to the American Association for the Advancement of Science, one in five healthy adults may carry such variants, without knowing it. If left unchecked, these mutations could profoundly impact their health, affect family members, or alter their responses to treatments. Recognizing the importance of understanding one’s genetic makeup, we envision a future where genetic sequencing is integral to healthcare, beginning at birth and throughout the various stages of life. To achieve our vision, we have developed a suite of personalized medicine services that currently cover the following categories: • Wellness & Prevention: preventative health solutions that integrate genetic, microbiome and lifestyle data, enabling individuals to understand how their unique genes and habits impact their long -termhealth. These solutions also provide actionable prevention recommendations, and will be supported by nutrigenetic specialists who will help craft personalized preventive health strategies tailored to each individual’s specific needs; and • Diagnostics, Prognosis & Monitoring: precise clinical genetic services integrated with clinical data to enable accurate diagnostics and informed treatment decisions, covering the fields of oncology, prenatal care, rare diseases and human microbiome. Our portfolio aims to empower individuals to understand and make decisions based on their genetic results. We achieve this by possessing a unique scientific know -howthat allows us to sequence biological samples in -houseand a R&D division that continuously works to